A study linking popular weight loss drug to suicide risk again raises long-standing safety questions

Editor’s Note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website.

People taking semaglutide, the popular medication for diabetes and weight loss, are more likely to report having thoughts of suicide compared with those taking other drugs, according to a new study of an international drug safety database. But the finding is the latest see-saw of scientific evidence on the risk of depression and suicide tied to the popular medications — and critics say evidence that the drugs cause problems with mood is limited.

A study linking popular weight loss drug to suicide risk again raises long-standing safety questions

Related:

Ian Douglas, London School of Hygiene & Tropical Medicine:

I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs – both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.

Previously:

Medicare to cover obesity drugs, but not for weight loss

Wegovy, Rybelsus, and Ozempic, are the different brand names for Semaglutide. They have a black box warning for Medullary thyroid cancer.* 🤦🏼‍♀️

Related:

Wegovy side effects: What you should know

*Obesity and Cancer

Everything We Learned From Oprah’s Weight Loss Special

Mounjaro:

Using Mounjaro may increase your risk of developing thyroid cancer.

How a false hydroxychloroquine narrative was created, and more

Meryl Nass, MD Alliance for Human Research Protection | June 28, 2020

Below, Dr. Meryl Nass reviews a long list of corrupt practices that undermine the integrity of medical science and the practice of medicine during the current medical crisis. The coronavirus crisis has been made significantly worse by stakeholders who are preventing doctors from prescribing for their patients, existing, safe and effective medicines, because the stakeholders are invested on garnering projected future profits from not-yet-developed vaccines and “countermeasures” specifically developed against COVID-19.

How a false hydroxychloroquine narrative was created, and more

Frequent boosters can weaken immunity, says EU

Frequent boosters can weaken immunity, says EU

Boosters “can be done once, or maybe twice, but it’s not something that we can think should be repeated constantly,” Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. “We need to think about how we can transition from the current pandemic setting to a more endemic setting.”

Does the Fate of Ivermectin As a Covid-19 Treatment Rest in the Hands of the Deeply Conflicted Bill & Melinda Gates Foundation?

One of the world’s biggest vaccine proponents and strident defender of intellectual property rights is funding, directly and indirectly, large trials into cheap, off-patent, off-label COVID-19 treatments, including ivermectin.

Does the Fate of Ivermectin As a Covid-19 Treatment Rest in the Hands of the Deeply Conflicted Bill & Melinda Gates Foundation?

INDIA: COVID-19 CASES PLUMMET AS THE COUNTRY TURNS TO IVERMECTIN AND HYDROXYCHLOROQUINE

India: COVID-19 cases plummet as the country turns to Ivermectin and hydroxychloroquine (H/T: The Free)

UPDATED May 17, 2021 – State of Tamil Nadu halts use of Ivermectin. Just like that, despite Ivermectin saving lives, The Hindu is reporting that the state health department removed Ivermectin from its case management protocols. This is murder with malice, no matter how you slice it.

More information and charts:

India Just Became Latest Country to Approve Use of Ivermectin to Treat Covid-19